Guntram Buesche

825 citations

20 papers · 513 indexed · h-index 12

Co-authors: A. Georgii Andreas Kreft T. Buhr Hans Kreipe Oliver Bock H. Choritz Brigitte Schlegelberger Hartmut Hecker
Topics: Acute Myeloid Leukemia Research (11 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers)Eosinophilic Disorders and Syndromes (6 papers)
Cited by: Genetics Hematology Rheumatology
Journals: Blood International Journal of Molecular Sciences American Journal Of Pathology
Partner nations: Germany United States Switzerland

In The Last Decade

Guntram Buesche

20 papers receiving 490 citations

Peers

Countries citing papers authored by Guntram Buesche

Since Specialization

Citations

This map shows the geographic impact of Guntram Buesche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guntram Buesche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guntram Buesche more than expected).

Fields of papers citing papers by Guntram Buesche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guntram Buesche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guntram Buesche. The network helps show where Guntram Buesche may publish in the future.

Co-authorship network of co-authors of Guntram Buesche

This figure shows the co-authorship network connecting the top 25 collaborators of Guntram Buesche. A scholar is included among the top collaborators of Guntram Buesche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guntram Buesche. Guntram Buesche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolution of severe (transfusion‐dependent) anaemia in myelodysplastic syndromes with 5q deletion is characterized by a macrophage‐associated failure of the eythropoietic niche 2022 ·British Journal of Haematology ·Guntram Buesche,(unknown),Rebekka K. Schneider,(unknown),Benjamin L. Ebert,Aristoteles Giagounidis,Gudrun Göhring,Brigitte Schlegelberger,Oliver Bock,Arnold Ganser,Carlo Aul,Ulrich Germing,Hans Kreipe	3
2	Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome 2019 ·Leukemia ·(unknown),Inge Snoeren,Susanne Ziegler,(unknown),(unknown),(unknown),Mónica Ventura Ferreira,Si Chen,(unknown),Guntram Buesche,Remco M. Hoogenboezem,Rafael Kramann,Uwe Platzbecker,Marc H.G.P. Raaijmakers,Benjamin L. Ebert,Rebekka K. Schneider	36
3	Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion 2018 ·International Journal of Molecular Sciences ·Simone Feurstein,Kathrin Thomay,Winfried Hofmann,Guntram Buesche,Hans Kreipe,Felicitas Thol,Michael Heuser,Arnold Ganser,Brigitte Schlegelberger,Gudrun Göhring	6
4	Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide 2015 ·Leukemia Research ·Fabian Beier,Behzad Kharabi Masouleh,Guntram Buesche,Mónica S. Ventura Ferreira,Rebekka K. Schneider,Patrick Ziegler,Stefan Wilop,(unknown),Norbert Gattermann,Uwe Platzbecker,Aristoteles Giagounidis,Katharina S. Götze,Florian Nolte,Wolf‐Karsten Hofmann,Detlef Haase,Hans Kreipe,Jens Panse,Marı́a A. Blasco,Ulrich Germing,Tim H. Brümmendorf	12
5	269 Mechanisms of action of lenalidomide on erythroblastic islands in patients with low- or intermediate-1-risk MDS with del(5q) chromosome abnormality 2011 ·Leukemia Research ·Guntram Buesche,Aristoteles Giagounidis,(unknown),Brigitte Schlegelberger,(unknown),Robert Knight,Carlo Aul,Hans Kreipe	1
6	Gene Therapy of Mpl Deficiency: Challenging Balance Between Leukemia and Pancytopenia 2009 ·Molecular Therapy ·(unknown),Johann Meyer,Guntram Buesche,Dirk Heckl,Hans Kreipe,Zhixiong Li,Karl Welte,Matthias Ballmaier,Christopher Baum,Ute Modlich	18
7	Anti-Angiogenic in-Vivo Effect of Lenalidomide and Its Impact On Neoplastic and Non-Neoplastic Hematopoiesis in MDS with Del(5q) Chromosome Abnormality. 2009 ·Blood ·Guntram Buesche,(unknown),Aristoteles Giagounidis,Gudrun Göhring,Brigitte Schlegelberger,Robert Knight,Carlo Aul,Hans Kreipe	8
8	Different involvement of the megakaryocytic lineage by the JAK2V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis 2007 ·Annals of Hematology ·Kais Hussein,Kai Brakensiek,Guntram Buesche,T. Buhr,Birgitt Wiese,Hans Kreipe,Oliver Bock	16
9	The expression levels of telomerase catalytic subunit hTERT and oncogenic MYC in essential thrombocythemia are affected by the molecular subtype 2007 ·Annals of Hematology ·Katharina Theophile,Guntram Buesche,Hans Kreipe,Oliver Bock	7
10	Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia 2007 ·Leukemia ·Guntram Buesche,Arnold Ganser,Brigitte Schlegelberger,Nils von Neuhoff,Dorothea Gadzicki,Hartmut Hecker,Oliver Bock,(unknown),Hans Kreipe	38
11	Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes 2007 ·Leukemia ·Guntram Buesche,(unknown),(unknown),Arnold Ganser,Hartmut Hecker,Ludwig Wilkens,Gudrun Göhring,Brigitte Schlegelberger,Oliver Bock,A. Georgii,Hans Kreipe	74
12	Aberrant Collagenase Expression in Chronic Idiopathic Myelofibrosis Is Related to the Stage of Disease but Not to the JAK2 Mutation Status 2006 ·American Journal Of Pathology ·Oliver Bock,(unknown),Kais Hussein,Kai Brakensiek,Guntram Buesche,T. Buhr,Birgitt Wiese,Hans Kreipe	32
13	In CML, Marrow Fibrosis Relapses or Emerges in 5 - 6 % of Patients Per Year Independently Indicating Imatinib Failure and Shortened Survival Time of Patients. 2006 ·Blood ·Guntram Buesche,Rüdiger Hehlmann,Arnold Ganser,Hartmut Hecker,Andreas Hochhaus,H. Heimpel,B Heinze,Claudia Schoch,Dorothea Gadzicki,Martin Mueller,Nils von Neuhoff,Susanne Schnittger,Brigitte Schlegelberger,(unknown),A. Georgii,Hans Kreipe	1
14	Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre‐staining processing of bone marrow biopsies 2005 ·Histopathology ·Guntram Buesche,A. Georgii,(unknown)	10
15	Anti-Angiogenic In Vivo Effect of Lenalidomide (CC-5013) in Myelodysplastic Syndrome with del(5q) Chromosome Abnormality and Its Relation to the Course of Disease. 2005 ·Blood ·Guntram Buesche,(unknown),Aristoteles Giagounidis,Oliver Bock,Ludwig Wilkens,Brigitte Schlegelberger,Robert Knight,John M. Bennett,Carlo Aul,Hans Kreipe	19
16	Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia 2004 ·Leukemia ·Guntram Buesche,Mathias Freund,Rüdiger Hehlmann,A. Georgii,Arnold Ganser,Hartmut Hecker,H. Heimpel,Christa Fonatsch,B Heinze,Markus Pfirrmann,Susana Holgado,(unknown),A Tobler,Joerg Hasford,T. Buhr,(unknown),(unknown)	6
17	Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia 2003 ·Human Pathology ·Guntram Buesche,A. Georgii,Anette Duensing,(unknown),Jérôme Schlué,Hans-Heinrich Kreipe	17
18	Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial 2003 ·Leukemia ·Guntram Buesche,R Hehlmann,Hartmut Hecker,H. Heimpel,B Heinze,(unknown),Markus Pfirrmann,Germán A. Gómez,A Tobler,Heinz Herrmann,Martin Kappler,Joerg Hasford,T. Buhr,(unknown),A. Georgii,(unknown)	42
19	2 The histopathology of chronic myeloproliferative diseases 1998 ·Baillière s Clinical Haematology ·A. Georgii,Guntram Buesche,Andreas Kreft	83
20	Classification and Staging of Ph-negative Myeloproliferative Disorders by Histopathology from Bone Marrow Biopsies 1996 ·Leukemia & lymphoma ·A. Georgii,T. Buhr,Guntram Buesche,Andreas Kreft,H. Choritz	84

About Guntram Buesche

Guntram Buesche is a scholar working on Hematology, Genetics and Rheumatology, having authored 20 papers that have together received 513 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Genetics (390 citations), Hematology (396 citations) and Rheumatology (149 citations). Guntram Buesche has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include A. Georgii, Andreas Kreft, T. Buhr, Hans Kreipe, Oliver Bock, H. Choritz, Brigitte Schlegelberger, Hartmut Hecker, Arnold Ganser and Gudrun Göhring. Their work appears in journals such as Blood, International Journal of Molecular Sciences and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact